ImmunologybioRxiv
Peptide vaccine candidate mimics the heterogeneity of natural SARS-CoV-2 immunity in convalescent humans and induces broad T cell responses in mice models
E. Somogyi, Z. Csiszovszki, L. Molnar…·E. R. Toke
This paper develops a peptide vaccine that mimics natural SARS-CoV-2 immunity and induces broad T cell responses in mice, validated across diverse human populations.
DOI 10.3389/fgene.2021.684152